News & Events
Featured Blog: TreeFrog Therapeutics Q&A
Today, we’re highlighting the groundbreaking work of TreeFrog Therapeutics, a company aimed at making stem cell-derived cell therapies more affordable and accessible to millions of patients. TreeFrog is a resident of our newest facility, LabCentral 238, with on-site capacities to kickstart collaborative cell therapy programs in regenerative medicine and immuno-oncology. We spoke with TreeFrog’s Cofounder and Chief Technology Officer, Kevin Alessandri, Ph.D., who just moved from Bordeaux to Boston, to learn more about the company’s focus and activities.
Gallery 1832
Gallery 1832 provides residents and visitors with new avenues to find inspiration in the space around them. We believe this constantly changing environment and exposure to new perspectives is beneficial to the mind. In this spirit, the gallery space is an important part of keeping life fresh for researchers and entrepreneurs.
News Articles
See All News
Press Releases
Founding sponsorship extended to additional locations Cambridge, MA – October 30, 2024 – Triumvirate Environmental and LabCentral are proud to announce the expansion of their long-standing…Read full post
$500,000 credit for private biomanufacturing lab space at LabCentral 238 supports growth trajectory for AI modeling biotech startupCAMBRIDGE, Mass., October 29, 2024 – LabCentral, the…Read full post
CAMBRIDGE, MA – October16, 2024 – LabCentral, the premier Massachusetts-based network of coworking labs designed to accelerate high-potential biotech startups, today unveiled a critical new program,…Read full post
World-renowned leaders to explore clinical, preclinical and investment landscapes for Alzheimer's and other diseases with a focus on novel hypotheses and clinical diversityCAMBRIDGE, Mass., Oct. 10,…Read full post
40+ Early-stage companies and Leading InvestorsCAMBRIDGE, Mass. – August 27, 2024 – LabCentral, BioLabs , and The Engine, today announced the first Boston Biotech Investor Day, to be held on…Read full post